RUNX1-deficiency drives immune-active ER+ mammary tumorigenesis through activation of interferon signaling
Sen Han, Dongxi Xiang, Xueqing Chen, Dongyi Zhao, Guyu Tracy Qin, Roderick Terry Bronson, Zhe Li
This study shows that RUNX1 loss in ER+ breast cancer promotes immune-active tumor formation through interferon signaling activation.
bioRxiv · Apr 9, 2026 · PreprintCancer Biology